Time-resolved fluorescence resonance energy transfer assay for point-of-care testing of urinary albumin

Clinical Chemistry

Volumn 49, Issue 7, 2003, Pages 1105-1113

  Qin, Qiu Ping ^a   Peltola, Olli ^b   Pettersson, Kim ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALBUMIN ANTIBODY; CHELATE; CYANINE DYE; EUROPIUM; FLUORESCENT DYE; MONOCLONAL ANTIBODY;

ACCURACY; ANTIBODY LABELING; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENERGY TRANSFER; EVALUATION; FLUORESCENCE ANALYSIS; FLUOROMETRY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MICROALBUMINURIA; MICROTITER PLATE ASSAY; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN URINE LEVEL; ROOM TEMPERATURE; SENSITIZATION; SIGNAL TRANSDUCTION; TIME RESOLVED FLUORESCENCE RESONANCE ENERGY TRANSFER ASSAY; URINALYSIS;

ALBUMINS; ALBUMINURIA; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CARBOCYANINES; CHELATING AGENTS; ENERGY TRANSFER; EUROPIUM; FLUORESCENT DYES; FLUOROIMMUNOASSAY; HUMANS; KINETICS; NEPHELOMETRY AND TURBIDIMETRY; POINT-OF-CARE SYSTEMS;

EID: 0038610969     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.7.1105     Document Type: Article

References (39)

1. Selvin PR. Principles and biophysical applications of lanthanide-based probes [Review]. Annu Rev Biophys Biomol Struct 2002;31:275-302.
2. Selvin PR. The renaissance of fluorescence resonance energy transfer [Review]. Nat Struct Biol 2000;7:730-4.
3. Mathis G. Rare earth cryptates and homogeneous fluoroimmunoassays with human sera [Review]. Clin Chem 1993;39:1953-9.
4. Szöllosi J, Damjanovich S, Matyus L. Application of fluorescence resonance energy transfer in the clinical laboratory: routine and research [Review]. Cytometry 1998;34:159-79.
5. Ullman EF, Schwarzberg M, Rubenstein KE. Fluorescent excitation transfer immunoassay. A general method for determination of antigens. J Biol Chem 1976;251:4172-8.
6. Lim CS, Miller JN, Bridges JW. Energy-transfer immunoassay: a study of the experimental parameters in an assay for human serum albumin. Anal Biochem 1980;108:176-84.
7. Morrison LE. Time-resolved detection of energy transfer: theory and application to immunoassays. Anal Biochem 1988;174:101-20.
8. Selvin PR, Hearst JE. Luminescence energy transfer using a terbium chelate: improvements on fluorescence energy transfer. Proc Natl Acad Sci U S A 1994;91:10024-8.
9. Bazin H, Trinquet E, Mathis G. Time resolved amplification of cryptate emission: a versatile technology to trace biomolecular interactions [Review]. J Biotechnol 2002;82:233-50.
10. Lundin K, Blomberg K, Nordstrom T, Lindqvist C. Development of a time-resolved fluorescence resonance energy transfer assay (cell TR-FRET) for protein detection on intact cells. Anal Biochem 2001;299:92-7.
11. Boisclair MD, McClure C, Josiah S, Glass S, Bottomley S, Kamerkar S, et al. Development of a ubiquitin transfer assay for high throughput screening by fluorescence resonance energy transfer. J Biomol Screen 2000;5:319-28.
12. Blomberg K, Hurskainen P, Hemmila I. Terbium and rhodamine as labels in a homogeneous time-resolved fluorometric energy transfer assay of the β subunit of human chorionic gonadotropin in serum. Clin Chem 1999;45:855-61.
13. Stenroos K, Hurskainen P, Eriksson S, Hemmila I, Blomberg K, Lindqvist C. Homogeneous time-resolved IL-2-IL-2R α assay using fluorescence resonance energy transfer. Cytokine 1998;10:495-9.
14. Kane SA, Fleener CA, Zhang YS, Davis LJ, Musselman AL, Huang PS. Development of a binding assay for p53/HDM2 by using homogeneous time-resolved fluorescence. Anal Biochem 2000;278:29-38.
15. Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving HH, Passa P, et al. Prevention of diabetic renal disease with special reference to microalbuminuria [Review]. Lancet 1995;346:1080-4.
16. American Diabetes Association. Diabetic nephropathy. Diabetes Care 2003;26(Suppl 1):S94-8.
17. Doumas BT, Peters T Jr. Serum and urine albumin: a progress report on their measurement and clinical significance [Review]. Clin Chim Acta 1997;258:3-20.
18. Parsons M, Newman DJ, Pugia M, Newall RG, Price CP. Performance of a reagent strip device for quantitation of the urine albumin: creatinine ratio in a point of care setting. Clin Nephrol 1999;51:220-7.
19. Parsons MP, Newman DJ, Newall RG, Price CP. Validation of a point-of-care assay for the urinary albumin:creatinine ratio. Clin Chem 1999;45:414-7.
20. Lövgren T, Merio L, Mitrunen K, Makinen ML, Makela M, Blomberg K, et al. One-step all-in-one dry reagent immunoassays with fluorescent europium chelate label and time-resolved fluorometry. Clin Chem 1996;42:1196-201.
21. Pettersson KS, Soderholm JR. Ultrasensitive two-site immunometric assay of human lutropin by time-resolved fluorometry. Clin Chem 1990;36:1928-33.
22. Qin QP, Christiansen M, Pettersson K. Point-of-care time-resolved immunofluorometric assay for human pregnancy-associated plasma protein A: use in first-trimester screening for Down syndrome. Clin Chem 2002;48:473-83.
23. Pettersson K, Katajamaki T, Irjala K, Leppanen V, Majamaa-Voltti K, Laitinen P. Time-resolved fluorometry (TRF)-based immunoassay concept for rapid and quantitative determination of biochemical myocardial infarction markers from whole blood, serum and plasma. Luminescence 2000;15:399-407.
24. Seethala R, Menzel R. A fluorescence polarization competition immunoassay for tyrosine kinases. Anal Biochem 1998;255:257-62.
25. Park YW, Cummings RT, Wu L, Zheng S, Cameron PM, Woods A, et al. Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence. Anal Biochem 1999;269:94-104.
26. Karvinen J, Hurskainen P, Gopalakrishnan S, Burns D, Warrior U, Hemmila I. Homogeneous time-resolved fluorescence quenching assay (LANCE) for caspase-3. J Biomol Screen 2002;7:223-31.
27. Takalo H, Mukkala VM, Mikola H, Liitti P, Hemmila I. Synthesis of europium(III) chelates suitable for labeling of bioactive molecules. Bioconj Chem 1994;5:278-82.
28. Schobel U, Egelhaaf HJ, Brecht A, Oelkrug D, Gauglitz G. New donor-acceptor pair for fluorescent immunoassays by energy transfer. Bioconj Chem 1999;10:1107-14.
29. Cullander C. Imaging in the far-red with electronic light microscopy: requirements and limitations [Review]. J Microsc 1994;176:281-6.
30. Lövgren T, Pettersson K. Time-resolved fluoroimmunoassay, advantages and limitations. In: Van Dyke K, Van Dyke R, eds. Luminescence immunoassay and molecular applications. Boca Raton, FL: CRC Press, 1990:233-53.
31. Youn HJ, Terpetschnig E, Szmacinski H, Lakowicz JR. Fluorescence energy transfer immunoassay based on a long-lifetime luminescent metal-ligand complex. Anal Biochem 1995;232:24-30.
32. Ozinskas AJ, Malak H, Joshi J, Szmacinski H, Britz J, Thompson RB, et al. Homogeneous model immunoassay of thyroxine by phase-modulation fluorescence spectroscopy. Anal Biochem 1993;213:264-70.
33. Thakkar H, Newman DJ, Holownia P, Davey CL, Wang CC, Lloyd J, et al. Development and validation of a particle-enhanced turbidimetric inhibition assay for urine albumin on the Dade aca analyzer. Clin Chem 1997;43:109-13.
34. Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, Azevedo MJ. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care 1997;20:516-9.
35. Rowe DJ, Dawnay A, Watts GF. Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in urine [Review]. Ann Clin Biochem 1990;27:297-312.
36. Howey JE, Browning MC, Fraser CG. Biologic variation of urinary albumin: consequences for analysis, specimen collection, interpretation of results, and screening programs. Am J Kidney Dis 1989;13:35-7.
37. Fraser CG. Desirable performance standards for clinical chemistry tests [Review]. Adv Clin Chem 1983;23:299-339.
38. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436-72.
39. Lydakis C, Lip GY. Microalbuminuria and cardiovascular risk [Review]. QJM 1998;91:381-91.